|
|||||
|
|
Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors |
|
| Authors: | Steven Deitelzweig W. Richey Neuman Melissa Lingohr-Smith Brandy Menges Jay Lin |
| Affiliation: | 1. Ochsner Clinic Foundation, Department of Hospital Medicine and The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA, USA;2. Portola Pharmaceuticals, South San Francisco, CA, USA;3. Novosys Health, Health Economics and Outcomes Research, Green Brook, NJ, USA |
| Abstract: | |
| Keywords: | Atrial fibrillation major bleeding factor Xa inhibitors healthcare resource use healthcare cost |